SHSE:600223

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Lushang Health Industry DevelopmentLtd

Executive Summary

Lushang Health Industry Development Co.,Ltd. More Details


Snowflake Analysis

Solid track record with excellent balance sheet.

Share Price & News

How has Lushang Health Industry DevelopmentLtd's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 600223 is more volatile than 75% of CN stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: 600223's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of CN stocks.


Market Performance


7 Day Return

10.9%

600223

-0.5%

CN Real Estate

2.9%

CN Market


1 Year Return

3.9%

600223

-6.0%

CN Real Estate

31.8%

CN Market

Return vs Industry: 600223 exceeded the CN Real Estate industry which returned -6% over the past year.

Return vs Market: 600223 underperformed the CN Market which returned 31.8% over the past year.


Shareholder returns

600223IndustryMarket
7 Day10.9%-0.5%2.9%
30 Day15.2%-1.6%7.2%
90 Day3.9%-7.0%11.5%
1 Year4.7%3.9%-2.9%-6.0%34.0%31.8%
3 Year152.8%147.3%-26.6%-32.6%23.1%17.0%
5 Year112.8%108.1%-3.4%-13.8%51.6%41.1%

Long-Term Price Volatility Vs. Market

How volatile is Lushang Health Industry DevelopmentLtd's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Lushang Health Industry DevelopmentLtd undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: 600223 (CN¥10.51) is trading below our estimate of fair value (CN¥97.57)

Significantly Below Fair Value: 600223 is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: 600223 is poor value based on its PE Ratio (18.3x) compared to the CN Real Estate industry average (14.8x).

PE vs Market: 600223 is good value based on its PE Ratio (18.3x) compared to the CN market (35.1x).


Price to Earnings Growth Ratio

PEG Ratio: 600223 is good value based on its PEG Ratio (0.8x)


Price to Book Ratio

PB vs Industry: 600223 is overvalued based on its PB Ratio (2.8x) compared to the CN Real Estate industry average (1.1x).


Next Steps

Future Growth

How is Lushang Health Industry DevelopmentLtd forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

21.9%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 600223's forecast earnings growth (21.9% per year) is above the savings rate (3.3%).

Earnings vs Market: 600223's earnings (21.9% per year) are forecast to grow slower than the CN market (24.4% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 600223's revenue (26.4% per year) is forecast to grow faster than the CN market (18.3% per year).

High Growth Revenue: 600223's revenue (26.4% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 600223's Return on Equity is forecast to be low in 3 years time (13.8%).


Next Steps

Past Performance

How has Lushang Health Industry DevelopmentLtd performed over the past 5 years?

35.0%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 600223 has high quality earnings.

Growing Profit Margin: 600223's current net profit margins (5.5%) are higher than last year (2.1%).


Past Earnings Growth Analysis

Earnings Trend: 600223's earnings have grown significantly by 35% per year over the past 5 years.

Accelerating Growth: 600223's earnings growth over the past year (156.6%) exceeds its 5-year average (35% per year).

Earnings vs Industry: 600223 earnings growth over the past year (156.6%) exceeded the Real Estate industry -4.1%.


Return on Equity

High ROE: 600223's Return on Equity (10.6%) is considered low.


Next Steps

Financial Health

How is Lushang Health Industry DevelopmentLtd's financial position?


Financial Position Analysis

Short Term Liabilities: 600223's short term assets (CN¥59.4B) exceed its short term liabilities (CN¥49.9B).

Long Term Liabilities: 600223's short term assets (CN¥59.4B) exceed its long term liabilities (CN¥5.5B).


Debt to Equity History and Analysis

Debt Level: 600223's debt to equity ratio (177.8%) is considered high.

Reducing Debt: 600223's debt to equity ratio has reduced from 277.7% to 177.8% over the past 5 years.

Debt Coverage: 600223's debt is well covered by operating cash flow (44.7%).

Interest Coverage: 600223 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Next Steps

Dividend

What is Lushang Health Industry DevelopmentLtd current dividend yield, its reliability and sustainability?

1.05%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: 600223's dividend (1.05%) is higher than the bottom 25% of dividend payers in the CN market (0.39%).

High Dividend: 600223's dividend (1.05%) is low compared to the top 25% of dividend payers in the CN market (1.81%).


Stability and Growth of Payments

Stable Dividend: Whilst dividend payments have been stable, 600223 has been paying a dividend for less than 10 years.

Growing Dividend: 600223's dividend payments have increased, but the company has only paid a dividend for 2 years.


Current Payout to Shareholders

Dividend Coverage: With its low payout ratio (19.2%), 600223's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Yanyong Li

9.58yrs

Tenure

Mr. Yanyong Li serves as the Chairman of the Board at Lushang Health Industry Development Co.,Ltd. (formerly known as Lushang Property Co.,Ltd.) since June 30, 2015 and serves as its General Manager.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Lushang Health Industry Development Co.,Ltd.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Lushang Health Industry Development Co.,Ltd.
  • Ticker: 600223
  • Exchange: SHSE
  • Founded: NaN
  • Industry: Real Estate Development
  • Sector: Real Estate
  • Market Cap: CN¥10.603b
  • Shares outstanding: 1.01b
  • Website: https://www.lshzy.com.cn

Number of Employees


Location

  • Lushang Health Industry Development Co.,Ltd.
  • Building 2
  • Jingzhou Road
  • Jinan
  • Shandong Province
  • China

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
600223SHSE (Shanghai Stock Exchange)YesDomestic SharesCNCNYJan 2000
600223XSSC (Shanghai Stock Exchange - Shanghai - Hong Kong Stock Connect)YesDomestic SharesCNCNYJan 2000

Biography

Lushang Health Industry Development Co.,Ltd. operates as a real estate development company in China. It develops boutique houses, urban complexes, shopping malls, grade A office buildings, high-star hotels...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/01/23 09:19
End of Day Share Price2021/01/22 00:00
Earnings2020/09/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.